Marc Pascal

3.2k total citations · 1 hit paper
55 papers, 2.5k citations indexed

About

Marc Pascal is a scholar working on Molecular Biology, Social Psychology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Pascal has authored 55 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Social Psychology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Pascal's work include Neuroendocrine regulation and behavior (11 papers), Electrolyte and hormonal disorders (6 papers) and Receptor Mechanisms and Signaling (6 papers). Marc Pascal is often cited by papers focused on Neuroendocrine regulation and behavior (11 papers), Electrolyte and hormonal disorders (6 papers) and Receptor Mechanisms and Signaling (6 papers). Marc Pascal collaborates with scholars based in France, Italy and Hungary. Marc Pascal's co-authors include Jean‐Pierre Maffrand, Jean‐Marc Herbert, Jean‐Marie Pereillo, Pierre Savi, C. Picard, Claudine Serradeil‐Le Gal, Jean Wagnon, Jean Combalbert, Philippe Soubrié and B. Scatton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Marc Pascal

54 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and Biological Activity of the Active Metabolite of Clopidogrel

2000 562 citations Pierre Savi, Jean‐Marie Pereillo et al. profile →

Peers

Countries citing papers authored by Marc Pascal

Since Specialization

Citations

This map shows the geographic impact of Marc Pascal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Pascal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Pascal more than expected).

Fields of papers citing papers by Marc Pascal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Pascal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Pascal. The network helps show where Marc Pascal may publish in the future.

Co-authorship network of co-authors of Marc Pascal

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Pascal. A scholar is included among the top collaborators of Marc Pascal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Pascal. Marc Pascal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decellularized Macroalgae as Complex Hydrophilic Structures for Skin Tissue Engineering and Drug Delivery 2024 ·Gels ·(unknown), Florina-Daniela Cojocaru, Marc Pascal, (unknown), (unknown), Cătălina A. Peptu, Maria Butnaru, Liliana Vereștiuc	2
2	In Vitro and in Vivo Pharmacological Characterization of Ethyl-4-{trans-4-[((2 S)-2-hydroxy-3-{4-hydroxy-3[(methylsulfonyl)amino]-phenoxy}propyl) Amino]cyclohexyl}benzoate Hydrochloride (SAR150640), a New Potent and Selective Human β3-Adrenoceptor Agonist for the Treatment of Preterm Labor 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Tiziano Croci, Roberto Cecchi, Pietro Marini, Céline Rouget, (unknown), Guy Germain, Fabio Guagnini, (unknown), Laurence Descamps, Marc Pascal, Charles Advenier, Michelle Breuiller-Fouché, Marie-Josèphe Leroy, Marc Bardou	22
3	Biological characterization of rodent and human vasopressin V_1breceptors using SSR-149415, a nonpeptide V_1breceptor ligand 2007 ·American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·Claudine Serradeil‐Le Gal, (unknown), Sylvain Derick, Jörg Blankenstein, John Carson Allen, Brigitte Pouzet, Marc Pascal, Jean Wagnon, (unknown)	22
4	SSR126768A (4-Chloro-3-[(3 R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2- oxo-2,3-dihydro-1 H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, Hydrochloride): A New Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Claudine Serradeil‐Le Gal, (unknown), (unknown), Guy Germain, Charles Advenier, Emmanuel Naline, Marc Bardou, (unknown), Brigitte Pouzet, Danielle Raufaste, Corinne Garcia, (unknown), (unknown), Marc Pascal, A. Barbier, B. Scatton, Jean‐Pierre Maffrand, Gérard Le Fur	41
5	Pancreatic vasopressin V_1breceptors: characterization in In-R1-G9 cells and localization in human pancreas 2003 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown), Danielle Raufaste, (unknown), Brigitte Pouzet, Pierrick Rochard, Marc Pascal, Claudine Serradeil‐Le Gal	47
6	Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V _1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders 2002 ·Proceedings of the National Academy of Sciences ·Guy Griebel, Jacques Simiand, Claudine Serradeil‐Le Gal, Jean Wagnon, Marc Pascal, B. Scatton, Jean‐Pierre Maffrand, Philippe Soubrié	381
7	Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Claudine Serradeil‐Le Gal, Jean Wagnon, Jacques Simiand, Guy Griebel, C Lacour, Gilles Guillon, Claude Barberis, (unknown), Philippe Soubrié, Dino Nisato, Marc Pascal, Rebecca M. Pruss, B. Scatton, Jean‐Pierre Maffrand, Gérard Le Fur	180
8	Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK₃ receptor antagonist 2002 ·Canadian Journal of Physiology and Pharmacology ·Xavier Emonds‐Alt, Vincenzo Proietto, R. Steinberg, Charles Advenier, (unknown), Emmanuel Naline, Christiane Gueudet, (unknown), Florence Oury-Donat, Martine Poncelet, P. Vilain, Gérard Le Fur, Jean‐Pierre Maffrand, Philippe Soubrié, Marc Pascal	26
9	Structure and Stereochemistry of the Active Metabolite of Clopidogrel 2002 ·Drug Metabolism and Disposition ·Jean‐Marie Pereillo, Mohamed Maftouh, (unknown), (unknown), Olivier Fedeli, Pierre Savi, Marc Pascal, Jean‐Marc Herbert, Jean‐Pierre Maffrand, C. Picard	356
10	Chapter 15 Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands 2002 ·Progress in brain research ·(unknown), Jean Wagnon, G Valette, Gabriela Garcia, Marc Pascal, J.P. Maffrand, G. Le Fur	76
11	SSR240600 [(R)-2-(1-{2-[4-{2-[3,5-Bis(trifluoromethyl)phenyl]acetyl}-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl}- 4-piperidinyl)-2-methylpropanamide], a Centrally Active Nonpeptide Antagonist of the Tachykinin Neurokinin-1 Receptor: I. Biochemical and Pharmacological Characterization 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Xavier Emonds‐Alt, Vincenzo Proietto, R. Steinberg, Florence Oury-Donat, Xavier Vigé, P. Vilain, Emmanuel Naline, (unknown), Charles Advenier, Gérard Le Fur, Jean‐Pierre Maffrand, Philippe Soubrié, Marc Pascal	13
12	Binding properties of a selective tritiated vasopressin V2 receptor antagonist, [3H]-SR 121463 2000 ·Kidney International ·Claudine Serradeil‐Le Gal, Danielle Raufaste, (unknown), Gilles Guillon, Corinne Garcia, Marc Pascal, Jean Pierre Maffrand	21
13	Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes 2000 ·FEBS Letters ·(unknown), Max Lafontan, Danielle Raufaste, Jean Marchand, Brigitte Pouzet, Pierre Casellas, Marc Pascal, Jean‐Pierre Maffrand, Gérard Le Fur	60
14	Glycosaminoglycans enhance megakaryocytopoiesis by modifying the activities of hematopoietic growth regulators 1996 ·Journal of Cellular Physiology ·Zhongchao Han, Sylvia Bellucci, Zhixiang Shen, Jean‐Pierre Maffrand, Marc Pascal, Maurice Petitou, J C Lormeau, J Caen	40
15	Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: Comparison between heparin-sensitive and heparin-resistant cultures 1996 ·Journal of Cellular Physiology ·Tereza Bârzu, Marc Pascal, (unknown), Claude Roque, Frank Lafont, Annie Rousselet	29
16	Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long‐term heparin treatment 1994 ·Journal of Cellular Physiology ·Tereza Bârzu, Marc Pascal, Jean‐Marc Herbert, Pierre Carayon, Alexis Desmoulière	23
17	Defined Glycosaminoglycan Motifs Have Opposite Effects on Neuronal Polarity in Vitro 1994 ·Developmental Biology ·Frank Lafont, Alain Prochiantz, (unknown), Maurice Petitou, Marc Pascal, (unknown), Annie Rousselet	42
18	(Benzoylphenyl)piperidines: a new class of immunomodulators 1991 ·Journal of Medicinal Chemistry ·F. BELLAMY, (unknown), Pierre Dodey, Patrick Dutartre, (unknown), Marc Pascal, Jacques Robin	4
19	Thymectomy at weaning. An accelerated aging model for the mouse immune system 1991 ·Mechanisms of Ageing and Development ·Patrick Dutartre, Marc Pascal	11
20	Detection of atherosclerotic plaque with two monoclonal antibodies 2P1A2 monoclonal antibody is specific for smooth muscle cells in atherosclerotic plaque 1988 ·Atherosclerosis ·J.-M. D. Lamaziere, Alexis Desmoulière, Marc Pascal, J Larrue	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact